IFN |
lncRNA-CMPK2 |
Blocking the transcription of ISGs |
Limit innate immune |
Enguita et al. (2022)
|
EGOT |
Downregulate the expression of several ISGs |
Limit innate immune |
Mukherjee et al. (2021)
|
LUCAT1 |
Reduce the expression of STAT-targets CXCR4 and NAMPT |
Limit innate immune |
Aznaourova et al. (2022)
|
CHROMR |
Promote the transcription of ISGs |
Promote innate immune |
van Solingen et al. (2022)
|
lnc02384 |
Increase the production of IFN-γ |
Promote innate immune |
Moazzam‐Jazi et al. (2021)
|
|
NETA1 |
Promote the expression of DDX60 and RIG-I |
Promote innate immune |
Ma et al. (2017)
|
TNF-α/IL-10 |
GAS5 |
Induced NLRP3、IL-10、TNF-α |
Inflammation |
Morenikeji et al. (2021)
|
NF-κB |
LUCAT1 |
Induced expression of proinflammatory markers CXCL2 and CXCL8 |
Inflammation |
Aznaourova et al. (2022)
|
PIRAT |
Reduce alarmin production |
Inflammation |
Aznaourova et al. (2022)
|
KCNQ1OT1 |
Interact with upregulated TLR2 |
Inflammation |
Turjya et al. (2020)
|
NORAD |
Induced IL-6、IL-10、CSF3、CXCL10、TNF-α |
Inflammation |
Morenikeji et al. (2021)
|
RAD51-AS1 |
Induced IL-6、TNF-α、CCL2 |
Inflammation |
Morenikeji et al. (2021)
|
MALAT1 |
Induced TNF-α、IL-6、IL-1 and CCL2 |
Inflammation |
Moazzam‐Jazi et al. (2021)
|
NEAT1 |
Induced TNF-α, IL-6, and IL-1, NLRP3, as well as CCl2, Ccl3, and CXCL10 |
Inflammation |
Moazzam‐Jazi et al. (2021)
|
Th17 cell differentiation |
CCR7-AS-1, LEF1-AS-1 |
T cell activation and differentiation |
Adaptive immune |
Zheng et al. (2020)
|
LINC-CCR7-2 |
LINC-TCF7-1 |
TCF7-AS -1 |
MAPK |
LINC-JUND-1, LINC-HSP90AA1-1, HIF1A-AS- |
T cell activation and differentiation |
Adaptive immune |
Zheng et al. (2020)
|